The SAGE Handbook of Clinical Neuropsychology -

The SAGE Handbook of Clinical Neuropsychology

Media-Kombination
1432 Seiten
2023
SAGE Publications Ltd
978-1-5297-1775-4 (ISBN)
369,95 inkl. MwSt
This handbook set provides an in-depth overview of Clinical Neuropsychology, from an understanding of specific cognitive disorders through to technical knowledge by which they can be assessed, diagnosed and treated. 
Clinical Neuropsychology is a vast and varied field that focuses on the treatment, assessment and diagnosis of a range of cognitive disorders through a study and understanding of neuroanatomy and the relationship between the brain and human behavior.

This two-volume set provide an in-depth overview of the Clinical Neuropsychological field, from an understanding of specific cognitive disorders through to technical knowledge by which they can be assessed, diagnosed and treated.

Volume One covers each of the classification systems involved before moving on to specific types of disorders from neurodevelopmental to neuropathological as well as brain injuries, trauma and neurodegenerative disorders.

Volume Two focuses on the assessment, diagnosis and rehabilitation of the cognitive disorders covered in the first volume.

Together they are an imperative resource that provide a comprehensive understanding of the field, and how to apply this understanding in clinical settings to effectively treat patients.

These handbooks are an essential site of reference for clinicians and scientists, as well as postgraduate students and researchers in a range of disciplines exploring the area.

Volume One: Clinical Neuropsychological Disorders

PART I BACKGROUND CONSIDERATIONS

PART II NEURODEVELOPMENTAL DISORDERS

PART III NEUROLOGICAL DISORDERS

PART IV NEUROCOGNITIVE DISORDERS

PART V TRAUMATIC BRAIN INJURY

PART VI PSYCHIATRIC DISORDERS


Volume Two: Clinical Neuropsychological Assessment and Diagnosis
PART I BACKGROUND CONSIDERATIONS

PART II DOMAIN-SPECIFIC NEUROPSYCHOLOGICAL MEASURES

PART III GENERAL COGNITIVE TEST BATTERIES

PART IV LEGACY NEUROPSYCHOLOGICAL TEST BATTERIES

PART V COMPUTERISED BATTERIES, TECHNOLOGICAL ADVANCES AND TELENEUROPSYCHOLOGY

PART VI NEUROPSYCHOLOGICAL ASSESSMENT APPLICATIONS

Professor Boyle has spent over three decades undertaking quantitative research in the field of psychometrics, as related to the measurement of individual differences in personality, intelligence, and motivation, as well as undertaking studies within the fields of neuropsychology, clinical psychology, and educational psychology. In more recent years, he has applied his extensive research skills to studies within the broad fields of medical/health psychology, and has undertaken many studies within the area of women′s health. Lately, he has focused his attention more on research topics pertaining to men′s health. Yaakov Stern is the Florence Irving Professor of Neuropsychology in the departments of Neurology and Psychiatry, as well as the Taub Institute for the Research on Alzheimer’s Disease and the Aging Brain and the Gertrude H. Sergievsky Center, at Columbia University Vagelos College of Physicians and Surgeons.  He is chief of the Cognitive Neuroscience Division of the Department of Neurology.  His research work focuses on cognition in normal aging and diseases of aging, including exploring the neural implementation of cognitive reserve, structural and functional imaging of cognitive aging, and modeling the natural history of Alzheimer’s disease. Dan J.  Stein is Professor and Chair of the Department of Psychiatry at the University of Cape Town, and Director of the South African Medical Research Council’s Unit on Risk and Resilience in Mental Disorders.  He is a clinician-scientist whose work has long focused on anxiety and related disorders, including obsessive-compulsive spectrum conditions and posttraumatic stress disorder.  He has influenced the field by extensive collaboration, mentorship, and publication. Barbara J Sahakian is Professor of Clinical Neuropsychology at the University of Cambridge Department of Psychiatry and Behavioural and Clinical Neuroscience Institute. She is also an Honorary Clinical Psychologist at Addenbrooke’s Hospital, Cambridge. She holds a PhD and a DSc from the University of Cambridge. She is a Fellow of the Academy of Medical Sciences and was President of the International Neuroethics Society (2014-2016) and the British Association for Psychopharmacology (2012-2014). In 2016, she was recipient of the Robert Sommer Award and the International College of Neuropsychopharmacology (CINP) Ethics Prize. Sahakian is also a Member of the International Expert Jury for the 2017 Else Kröner-Fresenius-Stiftung Prize dedicated to the biological basis of psychiatric disorders. She is co-author of ‘Bad Moves: How decision making goes wrong and the ethics of smart drugs’ (Oxford University Press, 2013) and of ‘Sex, Lies and Brain Scans. How fMRI reveals what really goes on in our minds’ (OUP, 2017). She is co-editor of The Oxford Handbook of Neuroethics (OUP, 2011) and Translational Neuropsychopharmacology (Current Topics in Behavioral Neurosciences) (Springer International Publishing, 2016). Sahakian has an international reputation in the fields of psychopharmacology, neuropsychology, neuropsychiatry, neuroimaging and neuroethics. She is perhaps best known for her work on ‘hot’ and ‘cold’ cognitive deficits in depression and early detection and early treatment with cholinesterase inhibitors in Alzheimer’s disease. She has over 400 publications in high impact scientific journals. Sahakian co-invented the neuropsychological CANTAB tests. Sahakian has contributed to Neuroscience and Mental Health Government Policy and has spoken on resilience, brain health, neuroscience and mental health at the World Economic Forum, Davos, 2014. She is a member of the World Economic Forum Global Agenda Council on Brain Research. Charles J. Golden is nationally and internationally known for his clinical research in neuropsychological assessment.  He has given over 1000 presentations, posters, and workshops, and published over 500 articles, book chapters, and books.  He is a Fellow of the American Psychological Association, and holds a Diplomate in Clinical Psychology, Clinical Neuropsychology, and Psychological Assessment.  He received the Distinguished Neuropsychologist Award from the National Association of Neuropsychologists in 2003.  He is the editor of Archives of Assessment Psychology and a past president of the National Academy of Neuropsychologists.  He is a Professor of Psychology at Nova Southeastern University.  Tatia Mei-Chun Lee is the Chair Professor of Psychological Science and Clinical Psychology and May Endowed Professor of Neuropsychology at The University of Hong Kong. She is also the Director of the State Key Laboratory of Brain and Cognitive Sciences and Laboratory of Neuropsychology and Human Neuroscience at the university. Her research focuses on the neuroplastic and neuropsychological underpinnings of brain and psychological health. She is an elected Fellow of learned societies, including the Academy of Social Sciences in the United Kingdom, the American Psychological Association (Society of Clinical Psychology and Society of Clinical Neuropsychology), and the Association for Psychological Science (Clinical Psychology). Annabel Chen Shen-Hsing is a Professor of Psychology and Director of Centre for Research and Development in Learning (CRADLE) at Nanyang Technological University (NTU), Singapore. She is a clinical neuropsychologist educated in the United States (Purdue University, West Virginia University, Medical College of Wisconsin) and conducted post-doctoral research in neuroimaging at the Lucas Centre, Stanford University School of Medicine. Her research seeks to understand disturbance in brain and behaviour using neuropsychological and neuroimaging techniques focusing on cerebellar contributions to higher cognition, optimizing cognition in aging neuroscience (active aging), and the science of learning to translate neuroscience for education.

The SAGE Handbook of Clinical Neuropsychology: Clinical Neuropsychological Disorders
Chapter 1: History and Advances in Clinical Neuropsychology - Gregory J. Boyle, Charles J. Golden, S.-H. Annabel Chen, Tatia M.-C. Lee, Dan J. Stein, Yaakov Stern, and Barbara J. Sahakian
Part 1: Background Considerations
Chapter 2: Role of DSM-5, ICD-11, and ICF/ICIDH-2 in Neuropsychological - Hannah E. Brunet, Mary L. Malik, Larry E. Beutler
Chapter 3: Neuropsychological applications related to the Research Domain Criteria (RDoC) - Scott A. Langenecker, Katie L. Bessette, Rebecca E. Easter, Leah Thomas, Mary L. Phillips, Mindy Westlund-Schreiner
Chapter 4: Clinical Neuropsychology in the Era of Neuroimaging - Dominique Makowski, S.-H. Annabel Chen, Rasmus Rosenberg Larsen, Scott O. Lilienfeld
Chapter 5: Genomics and phenomics - Katherine Lopez, Ruben C. Gur, Raquel E. Gur
Chapter 6: Neurobiology of Decision-Making - Jon E. Grant, Austin Blum
Chapter 7: Sex differences in neurocognitive domains - Ruben C. Gur, Katherine Lopez, Tyler M. Moore, Raquel E. Gur
Chapter 8: Cognitive Reserve in Healthy Aging and Neurodegenerative Disease - Eleanna Varangis, Anja Soldan, Yaakov Stern
Chapter 9: Global challenges in neuropsychology - Boyle et al.
Part 2: Neurodevelopmental Disease
Chapter 10: Intellectual disabilities - Kerim Munir
Chapter 11: Communication disorders - Deanna Swain, Rebecca Elias, Elysha Clark-Whitney, So Hyun Kim
Chapter 12: Autism spectrum disorder - Li Fei, Mingyu Xu, Juehua Yu, Miao Cao
Chapter 13: Attention-deficit/Hyperactivity disorder - Alysa E. Doyle, David R. Coghill, Tobias Banaschewski
Chapter 14: Specific learning disorders - H. Lee Swanson, Jennifer Kong, Stefania Petcu
Chapter 15: Motor disorders - Andrea E. Cavanna, Andrea Nani
Part 3: Neurological Disorders
Chapter 16: Motor neuron disease and related autoimmune disorder - Niall P. Pender, Marwa Elamin, Thomas Burke, Orla Hardiman
Chapter 17: Multiple sclerosis and other demyelinating disorders - Peter A. Arnett, Anthony Feinstein, John DeLuca
Chapter 18: Disorders of Purposeful Movements: Motor Intentional and Apraxic Disorders - Parunyou Julayanont, Kenneth M. Heilman
Chapter 19: Epileptic disorders - Gus A Baker, Sallie A. Baxendale
Chapter 20: Aphasias - Alfredo Ardila, Monica Rosselli
Chapter 21: Normal pressure hydrocephalus - Kayci L. Vickers, Robert McGovern, Felicia C. Goldstein
Chapter 22: Parkinson’s Disease - Angelo Antonini, Roberta Biundo
Chapter 23: Huntington’s disease - Julie C. Stout, Sarah L. Mason, Maria A. Rossetti
Part 4: Neurocognitive Disorders
Chapter 24: Delirium and Neuropsychological Disturbances - David J. Meagher, Dimitrios Adamis
Chapter 25: Mild cognitive impairment - Junhong Yu, Charlene L. M. Lam, Tatia Mei-Chun Lee
Chapter 26: Alzheimer’s disease - Michael M. Saling, Charles Malpas, Rachel F. Buckley
Chapter 27: Frontotemporal lobar - Megan Barker, Hannah Silverman, Stephanie Cosentino
Chapter 28: Lewy body disease - David P. Salmon, Denis S. Smirnov, J. Vincent Filoteo
Chapter 29: Vascular neurocognitive disorders - Esther van den Berg, Roy P.C. Kessels
Chapter 30: Neurocognition in HIV Patients: Evidence from CANTAB Battery - Amy R. Bland, Rebecca Elliott, Barbara J. Sahakian
Chapter 31: Creutzfeldt-Jakob and prion diseases - Carlton S. Gass, Ashok K. Verma
Part 5: Traumatic Brain Injury
Chapter 32: Moderate and Severe Traumatic Brain Injury - Alexander Olsen, Andrew P. Cwiek, Emily L. Dennis, Frank G. Hillary
Chapter 33: Post-concussion Syndrome - Molly J. Sullan, Aliyah Snyder
Chapter 34: Chronic traumatic Encephalopathy - Bennet I. Omalu, Jennifer L. Hammers
Part 6: Psychiatric Disorders
Chapter 35: Post-traumatic stress disorder (PTSD - Mark S. Greenberg, Kristin W. Samuelson, Roger K. Pitman
Chapter 36: Sleep-wake disorders - Michelle Olaithe, Romola S. Bucks, Maria Pushpanathan, Ivana Rosenzweig
Chapter 37: Alcohol-related disorders - Claudia Padula, Timothy C. Durazzo, Dieter J. Meyerhoff
Chapter 38: Substance abuse, prescribed medications, and toxin exposure - James J. Mahony, Liv E. Miller, Marc W. Haut
Chapter 39: Personality disorders - Anthony C. Ruocco, Elizabeth Infante, Liam Wright
Chapter 40: Neuropsychological impairment in psychotic disorders - Avi Reichenberg, Anthony S. David, Nina Zaks
Chapter 41: Neuropsychology and mental illness in youth - Stephen J. Wood, Kelly A. Allott
The SAGE Handbook of Clinical Neuropsychology: Clinical Neuropsychological Assessment and Diagnosis
Chapter 1: History and Advances in Clinical Neuropsychological Assessment - Gregory J. Boyle, Charles J. Golden, S.-H. Annabel Chen, Tatia M.-C. Lee, Dan J. Stein, Yaakov Stern, Barbara J. Sahakian
Part 1: Background Considerations
Chapter 2: Neuropsychological Test-Usage Practices - Laura A. Rabin, Caroline O. Nester, William B. Barr
Chapter 3: Ecological validity of neuropsychological tests - Dirk Bertens, Luciano Fasotti, Roy P.C. Kessels
Chapter 4: Assessment of invalid presentations in neuropsychological evaluations - Julie A. Suhr, Tatia Mei-Chun Lee
Chapter 5: Personality assessment in neuropsychological evaluations - Boyle et al.
Chapter 6: Neuropsychological assessment of cognitive reserve - Adam Bentvelzen, Russell J. Chander, Heidi Foo, Teresa Lee, Darren M. Lipnicki, Perminder S. Sachdev
Chapter 7: Cognitive test norms in multicultural, multiracial, multilanguage, multi-opportunity South Africa - Ann B. Shuttleworth-Edwards
Chapter 8: Neuropsychological Assessment and the Cattell-Horn-Carroll (CHC) Model - ModelJames B. Hoelzle, Mary U. Simons, Gregory J. Meyer, Kevin S. McGrew
Part 2: Domain-Specific Neuropsychological Measures
Chapter 9: Measures of language and communication - Maria Varkanitsa, Swathi Kiran, Klaus Willmes
Chapter 10: Measures of short-term working memory - Adam Culbreth, James M. Gold
Chapter 11: Measures of episodic-autobiographical memories - Hans J. Markowitsch, Johannes Schröder, Andreas Kordon, Angelica Staniloiu
Chapter 12: Measures of executive functions - Cutter Lindberg, Joel H. Kramer
Chapter 13: Measures of executive dysfunction and their localization - Joseph A. Mole, Lisa Cipolotti
Chapter 14: Measures of social cognition - Skye McDonald, Michelle Kelly
Chapter 15: Measures of Affective Cognition: EMOTICOM - Vibeke H. Dam, Christelle Langley, Dea S. Stenbæk, Barbara J. Sahakian
Chapter 16: MSCEIT Measure of Emotional Intelligence - Madison K. Clement, John D. Mayer, Jill A. McGaughy
Part 3: General Cognitive Battery Tests
Chapter 17: Wechsler Memory and Intelligence Scales: CHC Analysis - Matthew R. Reynolds, Jodene Fine, Christopher R. Niileksela, Lazar Stankov, Gregory J. Boyle
Chapter 18: Wechsler Adult Intelligence Scale (WAIS-IV) and Wechsler Memory Scale (WMS-IV): Critical Evaluation - Joseph J. Ryan, Samuel T. Gontkovsky
Chapter 19: Woodcock-Johnson IV Tests of Cognitive Abilities (WJ IV COG) - Daniel C. Miller, James Whittaker, Richard W. Woodcock
Chapter 20: Stanford-Binet Intelligence Scale (SB6 and early SB5) - Gale H. Roid, Elizabeth A. Allen
Part 4: Legacy Neuropsychological Test Batteries
Chapter 21: Legacy Neuropsychological Batteries: Halstead-Reitan Neuropsychological Battery (HRNB) - Charles J. Golden, Gregory J. Boyle, Elbert W. Russell
Chapter 22: Legacy Neuropsychological Batteries: Luria-Nebraska Neuropsychological Battery (LNNB) - Charles J. Golden, Gregory J. Boyle
Chapter 23: Halstead-Russell Neuropsychological Evaluation System - Revised (HRNES-R): Historical overview - Elbert W. Russell, Sally Russell, Brent P. Kolitz, Gregory J. Boyle
Chapter 24: Neuropsychological Assessment Battery (NAB) - Thomas A. Crum Samuel T. Gontkovsky, Gordon Teichner, Robert A. Stern
Chapter 25: Paediatric neuropsychological batteries - Boyle et al.
Part 5: Computerised Batteries, Technological Advances and Teleneuropsychology
Chapter 26: Clinical utility of computerized neurocognitive testing - C. Thomas Gualtieri
Chapter 27: Technological advances: Teleneuropsychology - Munro Cullum, Lana Harder, Rene Stolwyk, Dustin B. Hammers
Chapter 28: Cambridge Neuropsychological Test Automated Battery (CANTAB) - Christelle Langley, Barbara J. Sahakian, Trevor Robbins
Chapter 29: NIH Toolbox® for the Assessment of Neurological and Behavioral - Julie N. Hook, Richard C. Gershon
Chapter 30: Automated Neuropsychological Assessment Metrics (ANAM) - Tresa M. Roebuck-Spencer, Andrea S. Vincent
Chapter 31: Continuous performance tests - Liang-Jen Wang, Shoou-Lian Hwang-Gu
Chapter 32: Measures of activities of daily living: (ADLs/IADLs) - Maureen Schmitter-Edgecombe, Tania Giovannetti
Chapter 33: Enhancing Effectiveness of Neuropsychological Assessment Batteries in Cognitive Drug Trials - Hank Riordan, Paul J. Moberg
Part 6: Neuropsychological Assessment Applications
Chapter 34: Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) - Samuel T. Gontkovsky
Chapter 35: An Overview of the Consortium to Establish a Registry for Alzheimer’s Disease Neuropsychological Assessment Battery - Gordon Teichner, Samuel T. Gontkovsky, Thomas A. Crum
Chapter 36: NINDS-CSN Neuropsychological Battery & Montreal Cognitive Assessment (MoCA) - Xin Xu, Sandra Freitas, Isabel Santana, Mário R. Simões, Vincent C. T. Mok, Christopher Li-Hsian Chen
Chapter 37: Immediate Post-concussion Assessment and Cognitive Testing (ImPACT) - Natalie S. Sherry, Mark R. Lovell
Chapter 38: Cognition in schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) - Philip D. Harvey
Chapter 39: Neuropsychological Assessment in a Forensic Setting - Erin D. Bigler
Chapter 40: Neuropsychological assessment before, during and after ‘awake’ brain - Guillaume Herbet, Hugues Duffau
Chapter 41: Role of Neuropsychological Assessment in Brain - Amanda Sacks-Zimmerman, Melinda A. Cornwell, Charles J. Golden, Gregory J. Boyle

Erscheint lt. Verlag 10.6.2023
Verlagsort London
Sprache englisch
Maße 184 x 246 mm
Gewicht 2820 g
Themenwelt Geisteswissenschaften Psychologie Allgemeine Psychologie
Geisteswissenschaften Psychologie Biopsychologie / Neurowissenschaften
Geisteswissenschaften Psychologie Verhaltenstherapie
ISBN-10 1-5297-1775-2 / 1529717752
ISBN-13 978-1-5297-1775-4 / 9781529717754
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Exploring the Science of the Mind

von Daniel Reisberg

Media-Kombination (2021)
WW Norton & Co
69,85